Role of dietary fibres in cardiometabolic diseases

Christina C Dahm; Fie Langmann; Anne Østergaard Nannsen; Daniel B Ibsen

doi:10.1097/MCO.0000000000001047

Role of dietary fibres in cardiometabolic diseases

Christina C Dahm^*, Fie Langmann, Anne Østergaard Nannsen, Daniel B Ibsen^*

^*Corresponding author for this work

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaper › Review › Research › peer-review

2 Citations (Scopus)

Abstract

PURPOSE OF REVIEW: This review highlights recent developments in understanding the role of dietary fibre and specific fibre types on risk and management of cardiometabolic disease with a focus on the causal pathways leading to cardiometabolic diseases, namely weight management, glycaemic control, and lipid levels, as well as the latest findings for cardiovascular disease outcomes such as coronary heart disease, stroke, and mortality. Evidence for mechanisms through gut microbiota are also briefly reviewed.

RECENT FINDINGS: Dietary fibre intake is associated with improved weight management, the extent of which may depend on the subtype of dietary fibre. Overall dietary fibre intake reduces blood glucose and HbA1c, however soluble fibres may be particularly effective in reducing HbA1c, fasting blood glucose and blood lipids. Individual meta-analyses and umbrella reviews of observational studies on dietary fibre, as well as major fibre types, observed inverse associations with incident coronary heart disease, stroke, and mortality due to cardiovascular disease. As different types of fibres exerted different health benefits, fibre diversity (i.e. combinations of fibres) should be further investigated.

SUMMARY: Dietary fibres improve both short-term and long-term cardiometabolic disease risk factors and outcomes, and thus should be on every menu.

Original language	English
Journal	Current Opinion in Clinical Nutrition and Metabolic Care
Volume	27
Issue	4
Pages (from-to)	355-360
Number of pages	6
ISSN	1363-1950
DOIs	https://doi.org/10.1097/MCO.0000000000001047
Publication status	Published - 1 Jul 2024

Keywords

Blood Glucose/metabolism
Cardiometabolic Risk Factors
Cardiometabolic disease
Cardiovascular Diseases/prevention & control
Cardiovascular disease
Dietary Fiber/administration & dosage
Dietary fibre
Gastrointestinal Microbiome/physiology
Glycaemic control
Humans
Lipids
Lipids/blood
cardiovascular disease
lipids
cardiometabolic disease
dietary fibre
glycaemic control

Access to Document

10.1097/MCO.0000000000001047

Library access?

Check availability with the Royal Danish Library

Cite this

@article{5e62fb2d2202426c8cb17c41037775eb,

title = "Role of dietary fibres in cardiometabolic diseases",

abstract = "PURPOSE OF REVIEW: This review highlights recent developments in understanding the role of dietary fibre and specific fibre types on risk and management of cardiometabolic disease with a focus on the causal pathways leading to cardiometabolic diseases, namely weight management, glycaemic control, and lipid levels, as well as the latest findings for cardiovascular disease outcomes such as coronary heart disease, stroke, and mortality. Evidence for mechanisms through gut microbiota are also briefly reviewed.RECENT FINDINGS: Dietary fibre intake is associated with improved weight management, the extent of which may depend on the subtype of dietary fibre. Overall dietary fibre intake reduces blood glucose and HbA1c, however soluble fibres may be particularly effective in reducing HbA1c, fasting blood glucose and blood lipids. Individual meta-analyses and umbrella reviews of observational studies on dietary fibre, as well as major fibre types, observed inverse associations with incident coronary heart disease, stroke, and mortality due to cardiovascular disease. As different types of fibres exerted different health benefits, fibre diversity (i.e. combinations of fibres) should be further investigated.SUMMARY: Dietary fibres improve both short-term and long-term cardiometabolic disease risk factors and outcomes, and thus should be on every menu.",

keywords = "Blood Glucose/metabolism, Cardiometabolic Risk Factors, Cardiometabolic disease, Cardiovascular Diseases/prevention & control, Cardiovascular disease, Dietary Fiber/administration & dosage, Dietary fibre, Gastrointestinal Microbiome/physiology, Glycaemic control, Humans, Lipids, Lipids/blood, cardiovascular disease, lipids, cardiometabolic disease, dietary fibre, glycaemic control",

author = "Dahm, {Christina C} and Fie Langmann and Nannsen, {Anne {\O}stergaard} and Ibsen, {Daniel B}",

year = "2024",

month = jul,

day = "1",

doi = "10.1097/MCO.0000000000001047",

language = "English",

volume = "27",

pages = "355--360",

journal = "Current Opinion in Clinical Nutrition and Metabolic Care",

issn = "1363-1950",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Role of dietary fibres in cardiometabolic diseases

AU - Dahm, Christina C

AU - Langmann, Fie

AU - Nannsen, Anne Østergaard

AU - Ibsen, Daniel B

PY - 2024/7/1

Y1 - 2024/7/1

N2 - PURPOSE OF REVIEW: This review highlights recent developments in understanding the role of dietary fibre and specific fibre types on risk and management of cardiometabolic disease with a focus on the causal pathways leading to cardiometabolic diseases, namely weight management, glycaemic control, and lipid levels, as well as the latest findings for cardiovascular disease outcomes such as coronary heart disease, stroke, and mortality. Evidence for mechanisms through gut microbiota are also briefly reviewed.RECENT FINDINGS: Dietary fibre intake is associated with improved weight management, the extent of which may depend on the subtype of dietary fibre. Overall dietary fibre intake reduces blood glucose and HbA1c, however soluble fibres may be particularly effective in reducing HbA1c, fasting blood glucose and blood lipids. Individual meta-analyses and umbrella reviews of observational studies on dietary fibre, as well as major fibre types, observed inverse associations with incident coronary heart disease, stroke, and mortality due to cardiovascular disease. As different types of fibres exerted different health benefits, fibre diversity (i.e. combinations of fibres) should be further investigated.SUMMARY: Dietary fibres improve both short-term and long-term cardiometabolic disease risk factors and outcomes, and thus should be on every menu.

AB - PURPOSE OF REVIEW: This review highlights recent developments in understanding the role of dietary fibre and specific fibre types on risk and management of cardiometabolic disease with a focus on the causal pathways leading to cardiometabolic diseases, namely weight management, glycaemic control, and lipid levels, as well as the latest findings for cardiovascular disease outcomes such as coronary heart disease, stroke, and mortality. Evidence for mechanisms through gut microbiota are also briefly reviewed.RECENT FINDINGS: Dietary fibre intake is associated with improved weight management, the extent of which may depend on the subtype of dietary fibre. Overall dietary fibre intake reduces blood glucose and HbA1c, however soluble fibres may be particularly effective in reducing HbA1c, fasting blood glucose and blood lipids. Individual meta-analyses and umbrella reviews of observational studies on dietary fibre, as well as major fibre types, observed inverse associations with incident coronary heart disease, stroke, and mortality due to cardiovascular disease. As different types of fibres exerted different health benefits, fibre diversity (i.e. combinations of fibres) should be further investigated.SUMMARY: Dietary fibres improve both short-term and long-term cardiometabolic disease risk factors and outcomes, and thus should be on every menu.

KW - Blood Glucose/metabolism

KW - Cardiometabolic Risk Factors

KW - Cardiometabolic disease

KW - Cardiovascular Diseases/prevention & control

KW - Cardiovascular disease

KW - Dietary Fiber/administration & dosage

KW - Dietary fibre

KW - Gastrointestinal Microbiome/physiology

KW - Glycaemic control

KW - Humans

KW - Lipids

KW - Lipids/blood

KW - cardiovascular disease

KW - lipids

KW - cardiometabolic disease

KW - dietary fibre

KW - glycaemic control

UR - http://www.scopus.com/inward/record.url?scp=85195435326&partnerID=8YFLogxK

U2 - 10.1097/MCO.0000000000001047

DO - 10.1097/MCO.0000000000001047

M3 - Review

C2 - 38836788

SN - 1363-1950

VL - 27

SP - 355

EP - 360

JO - Current Opinion in Clinical Nutrition and Metabolic Care

JF - Current Opinion in Clinical Nutrition and Metabolic Care

IS - 4

ER -

Role of dietary fibres in cardiometabolic diseases

Abstract

Keywords

Access to Document

Library access?

Other files and links

Fingerprint

Cite this